Stockholders' (Deficiency)/Equity (Details Narrative) (USD $)	3 Months Ended	9 Months Ended		219 Months Ended										3 Months Ended
	Apr. 30, 2014	Apr. 30, 2014	Apr. 30, 2013	Apr. 30, 2014	Jul. 31, 2013	Apr. 30, 2014 Various Consultants	Apr. 30, 2014 Employee Compensation	Jun. 17, 2014 Series E Convertible Preferred Stock	Jan. 15, 2014 Series E Convertible Preferred Stock	Apr. 30, 2014 Series F Convertible Preferred Stock	Apr. 30, 2014 Make-Whole Dividend Payments	Apr. 30, 2014 Upon Exercise Of Warrants	Apr. 30, 2014 Upon Exercise Of Options	Apr. 30, 2014 Executives, Directors, Employees	Apr. 30, 2014 Warrant Expiration Date 31 March 2016	Apr. 30, 2014 Warrant Expiration Date 30 September 2016	Apr. 30, 2014 Warrant Expiration Date 1 February 2017	Apr. 30, 2014 Warrant Expiration Date 10 August 2017	Apr. 30, 2014 Warrant Expiration Date 12 December 2017	Apr. 30, 2014 Warrant Expiration Date 17 June 2018	Apr. 30, 2014 Total Warrants	Apr. 30, 2014 Board Approved Equity Program	Apr. 30, 2014 Approved In Good Faith
Common stock issued, or committed to issue, Shares						5,683,333	4,333,333	64,499,998			18,000,194	76,732,020	526,306									5,608,926	11,217,852
Common stock issued, or committed to issue, Amount	$ 750,103	$ 750,103		$ 750,103	$ 580,329	$ 230,500	$ 130,000		$ 26,666,668			$ 2,301,961
Common stock, value per share	$ 0.001	$ 0.001		$ 0.001	$ 0.001	$ 0.03	$ 0.03					$ 0.03	$ 0.001
Common stock, value per share (Maximum)						$ 0.15
Conversion of shares of Series E, Convertible Preferred Stock								1,705
Conversion of shares of Series F, Convertible Preferred Stock										230
Additional value or warrant exercised												2,194,496
Charge to operations, stock option expense				4,011,938										5,365
Repayment of deferred salaries	257,505	257,505		257,505
Cash proceeds													526
Outstanding warrants, weighted average exercise price	$ 0.085
Outstanding warrants, weighted average remaining life (in years)	3 years 15 days
Number of shares to be purchased	238,229,939	238,229,939		238,229,939											64,516,758	27,272,720	5,675,227	4,999,999	8,324,144	34,166,669	26,666,668
Number of shares to be purchased, exercise price	$ 0.03	$ 0.03		$ 0.03	$ 0.03										$ 0.03	$ 0.03	$ 0.03	$ 0.03	$ 0.03	$ 0.03	$ 0.03
Percentage of common stock issued and outstanding																						5.00%	10.00%
Estimated value of warrants	95,833,335
Increase in equity	$ 237,566	$ 237,566		$ 237,566